1. Home
  2. LIXT vs PRSO Comparison

LIXT vs PRSO Comparison

Compare LIXT & PRSO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LIXT
  • PRSO
  • Stock Information
  • Founded
  • LIXT 2005
  • PRSO 2008
  • Country
  • LIXT United States
  • PRSO United States
  • Employees
  • LIXT N/A
  • PRSO N/A
  • Industry
  • LIXT Biotechnology: Pharmaceutical Preparations
  • PRSO Semiconductors
  • Sector
  • LIXT Health Care
  • PRSO Technology
  • Exchange
  • LIXT Nasdaq
  • PRSO Nasdaq
  • Market Cap
  • LIXT 4.2M
  • PRSO 4.2M
  • IPO Year
  • LIXT N/A
  • PRSO 2001
  • Fundamental
  • Price
  • LIXT $1.62
  • PRSO $0.83
  • Analyst Decision
  • LIXT
  • PRSO Strong Buy
  • Analyst Count
  • LIXT 0
  • PRSO 2
  • Target Price
  • LIXT N/A
  • PRSO $3.38
  • AVG Volume (30 Days)
  • LIXT 1.8M
  • PRSO 338.3K
  • Earning Date
  • LIXT 11-12-2024
  • PRSO 11-12-2024
  • Dividend Yield
  • LIXT N/A
  • PRSO N/A
  • EPS Growth
  • LIXT N/A
  • PRSO N/A
  • EPS
  • LIXT N/A
  • PRSO N/A
  • Revenue
  • LIXT N/A
  • PRSO $12,727,000.00
  • Revenue This Year
  • LIXT N/A
  • PRSO $17.49
  • Revenue Next Year
  • LIXT N/A
  • PRSO $0.67
  • P/E Ratio
  • LIXT N/A
  • PRSO N/A
  • Revenue Growth
  • LIXT N/A
  • PRSO N/A
  • 52 Week Low
  • LIXT $1.31
  • PRSO $0.73
  • 52 Week High
  • LIXT $4.42
  • PRSO $11.20
  • Technical
  • Relative Strength Index (RSI)
  • LIXT 43.04
  • PRSO 29.83
  • Support Level
  • LIXT $1.56
  • PRSO $0.92
  • Resistance Level
  • LIXT $1.87
  • PRSO $1.17
  • Average True Range (ATR)
  • LIXT 0.23
  • PRSO 0.23
  • MACD
  • LIXT -0.03
  • PRSO -0.10
  • Stochastic Oscillator
  • LIXT 8.33
  • PRSO 6.83

About LIXT Lixte Biotechnology Holdings Inc.

Lixte Biotechnology Holdings Inc is a biopharmaceutical company dedicated to improving patients' lives by developing a drug class called Protein Phosphatase 2A inhibitors. Its product pipeline is focused on inhibitors of protein phosphatase 2A, used in combination with cytotoxic agents and/or x-rays, immune checkpoint blockers, and other cancer therapies. The Company believes that inhibitors of protein phosphatases have therapeutic potential for a broad range of cancers. It focuses on the clinical development of a specific protein phosphatase inhibitor, referred to as LB-100, which has been shown to have clinical anti-cancer activity at doses that produce little or no toxicity.

About PRSO Peraso Inc.

Peraso Inc is a fabless semiconductor company focused on the development and sale of: i) millimeter wavelength wireless technology, or mmWave, semiconductor devices and antenna modules based on its proprietary semiconductor devices and ii) performance of non-recurring engineering, or NRE, services and licensing of intellectual property, or IP. The company's primary focus is the development of mmWave, which is generally described as the frequency band from 24 Gigahertz, or GHz, to 300 GHz. Geographically the company generates revenue from the United States, Hong Kong, Taiwan, and the Rest of the World.

Share on Social Networks: